Spatial Genomics and Transcriptomics Market Future Trends & Growth
The global spatial genomics and transcriptomics market is expected to grow from USD 355 million in 2022 to USD 800 million by 2027, exhibiting a robust CAGR of 17.6%. This growth is primarily driven by the increasing adoption of spatial genomics and transcriptomics techniques in drug discovery and development. Additionally, the rise in research and development investments and public-private funding,...
RNA Analysis Market: Increasing Demand for Personalized Medicine
The RNA
analysis market is projected to reach USD 8.7 billion by 2025 from USD 4.5
billion in 2020, at a CAGR of 13.9% during the forecast period.
The growth of this market is majorly driven
by the increasing demand for personalized medicine, increasing pharmaceutical
and biotechnology R&D expenditure and government funding for omics, and the
increasing applications of RNA sequencing in the...
RNA Analysis Market: Increasing Demand for Personalized Medicine
The RNA analysis market is projected to reach USD 8.7 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 13.9% during the forecast period.
The growth of this market is majorly driven by the increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding for omics, and the increasing applications of RNA sequencing...
RNA Analysis Market: Increasing Demand for Personalized Medicine
The RNA analysis market is projected to reach USD 8.7 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 13.9% during the forecast period.
The growth of this market is majorly driven by the increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding for omics, and the increasing applications of RNA sequencing...
RNA Analysis Market worth $8.7 Billion by 2025
The RNA
analysis market is projected to reach USD 8.7 billion by 2025 from USD 4.5
billion in 2020, at a CAGR of 13.9% during the forecast period.
Growth in this market is primarily driven by the increasing
demand for personalized medicine, increasing pharmaceutical and biotechnology
R&D expenditure and government funding for omics, and the increasing
applications of RNA sequencing in the...